Wednesday, November 21st, 2012...9:27 pm
Q3 2012 Drug Sales Data Released: Nexium and Abilify Remain the Leading Brands
The latest U.S. drug sales data has been released by Drugs.com. As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck’s asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. AstraZeneca’s Nexium, not forecast to lose patent protection until May 2014, once again holds the top spot with over $1.42 billion in sales.
View the data here…
View the press release here…